不同经三尖瓣途径置入永久起搏器导线对三尖瓣反流的影响:随机开放标签优效性临床试验研究方案
本研究为随机、开放标签、优效性临床试验方案,计划在汕头大学医学院第一附属医院招募376例接受右心室单腔或双腔起搏器植入的受试者,随机分为直穿组(直穿和下落)与弯曲组(脱垂),主要终点为随访1年内新发三尖瓣反流或原有三尖瓣反流加重。研究旨在验证不同经瓣途径是否影响导线诱发三尖瓣反流的发生率,以期为常规起搏器手术提供优化方法。
要点
- 计划纳入376例右心室单腔或双腔起搏器植入受试者,随机分为直穿组与弯曲组。
- 主要终点为随访1年内新发三尖瓣反流或原有三尖瓣反流加重。
- 研究旨在验证不同经瓣途径对导线诱发三尖瓣反流发生率的影响。
核心结论
- 本研究旨在验证不同经瓣途径是否影响导线诱发三尖瓣反流的发生率,并期望为常规起搏器手术提供优化方法、改善患者长期预后与生活质量。
研究设计与样本
- 随机、开放标签、优效性临床试验方案,计划在汕头大学医学院第一附属医院招募376例接受右心室单腔或双腔起搏器植入的受试者。
- 受试者随机分为直穿组(直穿和下落)与弯曲组(脱垂)。
关键数值与推荐
- 主要终点为随访1年内新发三尖瓣反流或原有三尖瓣反流加重。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In recent years, lead-induced tricuspid regurgitation (LITR) has attracted increasing attention. At present, there are two commonly used transvalvular methods for pacing lead wires to enter the right ventricle. The first transvalvular approach involves placing the tip of the pacing lead directly through the tricuspid valve into the right ventricle, including "direct-crossing" and "drop-down." The second transvalvular approach is to bend the pacing lead so that the reflexed lead body crosses the tricuspid valve and then enters the right ventricle, which is "prolapsing." However, there are no clinical trials to evaluate or compare the effects of the above two different pacing lead transvalvular approaches on tricuspid regurgitation. In this study, we will perform a randomized clinical trial to understand the effect of different transvalvular lead wire transversal techniques on the incidence of tricuspid regurgitation. METHODS: Three hundred seventy-six subjects with right ventricular single-chamber pacemaker implantation or dual-chamber pacemaker implantation were recruited in the First Affiliated Hospital of Shantou University Medical College. Participants will be randomized into the direct group ("direct-crossing" and "drop-down") or the bending group ("prolapsing"). The primary objective will be new tricuspid regurgitation or exacerbation of existing tricuspid regurgitation within 1 year of follow-up. DISCUSSION: This study aims to verify whether different transvalvular approaches influence the incidence of LITR, and is expected to provide an optimized method for routine pacemaker surgery and improve the long-term prognosis and quality of life of patients. TRIAL REGISTRATION: Chinese Clinical Trials Registry ChiCTR2100045558. Registered on April 19, 2021.
引用
- Hong J, Qiu Z, Xiao Z, et al. Effects on tricuspid regurgitation by different techniques for passing permanent pacemaker leads through the tricuspid valve: a randomized, open-label, superiority clinical trial study protocol. Trials. 2024. PMID: 39548601. doi:10.1186/s13063-024-08630-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。